Arrowhead Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | 188.6 | 57.6 | 40.3 | 115.6 | 307.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 46.2 | – | – | |
| 3,339.1 | 25.5 | 10.6 | 5.3 | 10.2 | 9.1 | 27.3 | 87.6 | 113.7 | 25.1 | 19.0 | 19.2 | 16.2 | 37.6 | 21.1 | 35.6 | 50.3 | 98.7 | 77.3 | 80.1 | 47.2 | 48.0 | 18.8 | 14.9 | 14.4 | 15.5 | 10.1 | 14.9 | 12.0 | 18.1 | 99.4 | 164.4 | 87.2 | 90.0 | 3.0 | 3.7 | 5.6 | 8.6 | 14.4 | 17.5 | |
| 5.5 | 1.2 | 1.5 | 1.3 | 4.0 | 3.9 | 5.3 | 11.6 | 19.2 | 6.9 | 9.0 | 11.6 | 11.2 | 12.3 | 5.9 | 8.9 | 9.6 | 17.3 | 15.5 | 19.7 | 16.0 | 18.6 | 11.0 | 8.2 | 8.8 | 11.4 | 6.1 | 10.5 | 10.6 | 20.5 | 7.3 | 9.8 | 12.8 | 44.6 | 2.5 | 4.2 | 10.0 | 16.4 | 14.5 | 25.1 | |
| 2,817.2 | 3.3 | 6.2 | 3.7 | 9.5 | 8.8 | 24.2 | 85.7 | 112.0 | 21.1 | – | – | 15.0 | 34.8 | 19.2 | 33.8 | 48.7 | 97.0 | 73.1 | 77.1 | 45.9 | 47.4 | 18.5 | 14.3 | 14.0 | 14.8 | 9.6 | 14.5 | 11.6 | 17.8 | 95.9 | 161.1 | 98.1 | 103.8 | 3.2 | 3.9 | 5.7 | 8.6 | 15.5 | 18.7 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 38.5 | 114.1 | 456.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 28.6 | 25.3 | – | – | |
| – | – | – | – | – | – | – | – | – | 8.9 | 13.9 | 17.3 | 17.0 | – | – | – | – | – | 41.7 | 51.5 | 44.2 | 56.0 | – | – | – | – | – | – | – | – | – | – | – | – | 178.0 | – | 29.8 | 29.0 | – | – | |
| -12.9% | -36.8% | -30.2% | -29.6% | -9.9% | -18.6% | -8.5% | -4.6% | -2.7% | 11.3% | 7.2% | 5.8% | 5.9% | -0.6% | -1.6% | -2.0% | -2.4% | -1.6% | 2.4% | 1.9% | 2.3% | 1.8% | -1.5% | -3.2% | -5.4% | -5.5% | -12.9% | -9.0% | -11.4% | -12.2% | -13.3% | -16.5% | -25.5% | -24.4% | 0.6% | -0.8% | 3.4% | 3.4% | -0.6% | -0.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.2% | 98.0% | 96.9% | 95.7% | 96.2% | 96.1% | 95.6% | 94.8% | 92.3% | 55.1% | 11.3% | -55.4% | -45.4% | 94.1% | 95.2% | 100.0% | 100.0% | 100.0% | 100.0% | |
| -51,627.1% | -1,725.5% | -463.2% | -213.6% | -117.8% | -117.5% | -201.7% | -404.5% | -346.5% | -65.9% | 6.2% | 29.5% | 36.3% | 27.7% | 0.8% | -27.0% | -105.9% | -140.7% | -132.8% | -124.7% | -107.8% | -130.4% | -45.0% | -63.8% | -73.4% | -56.5% | -55.2% | -70.4% | -85.2% | -164.7% | -1,335.6% | -2,785.1% | -2,214.7% | -2,399.3% | -20.8% | -18.1% | 11.9% | 27.6% | -35.7% | -33.8% | |
| -51,614.6% | -1,663.9% | -445.3% | -201.8% | -109.5% | -116.2% | -199.6% | -400.1% | -337.3% | -61.8% | 10.1% | 33.3% | 40.3% | 32.6% | 6.9% | -19.7% | -96.1% | -128.5% | -123.0% | -117.0% | -101.9% | -126.7% | -42.4% | -61.6% | -72.4% | -55.5% | -55.1% | -70.7% | -85.3% | -163.3% | -1,327.2% | -2,741.4% | -2,208.9% | -2,452.0% | -25.3% | -24.9% | -0.2% | 18.5% | -48.4% | -47.8% | |
| -43,129.2% | -938.1% | -319.4% | -156.0% | -101.4% | -168.2% | -231.9% | -401.2% | -301.3% | 282.8% | 136.9% | 110.9% | 95.4% | -21.0% | -32.9% | -71.7% | -122.0% | -153.7% | 185.4% | 155.4% | 106.8% | 85.7% | -28.5% | -47.9% | -77.6% | -84.9% | -129.5% | -133.5% | -137.1% | -221.2% | -1,323.5% | -2,707.5% | -2,226.7% | -2,191.0% | 1.7% | -3.0% | 18.9% | 29.5% | -8.2% | -11.2% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -85.5% | -76.2% | -63.7% | -50.9% | -42.2% | -50.2% | -38.8% | -53.2% | -56.8% | -17.0% | 4.8% | 20.1% | 27.8% | 10.7% | 1.9% | -5.0% | -18.3% | -22.6% | -24.6% | -28.8% | -34.5% | -49.1% | -24.7% | -33.9% | -44.2% | -41.0% | -33.6% | -49.6% | -75.7% | -185.0% | -97.3% | -163.0% | -323.3% | -1,216.4% | -21.1% | -28.4% | -0.3% | 35.6% | -49.0% | -68.7% | |
| -63.8% | -51.7% | -47.1% | -39.9% | -33.1% | -40.2% | -34.9% | -48.2% | -48.8% | -8.6% | 2.9% | 13.5% | 19.4% | 9.1% | 1.7% | -4.4% | -16.2% | -20.6% | -14.5% | -17.1% | -19.8% | -28.7% | -15.9% | -20.5% | -25.4% | -17.3% | -16.9% | -22.8% | -26.8% | -47.4% | -49.3% | -60.9% | -52.6% | -63.1% | -9.1% | -10.8% | -0.1% | 12.6% | -13.3% | -15.1% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -83 | -99 | -59 | -36 | -22 | -9.0 | -67 | -26 | -28 | -190 | – | – | -210 | -461 | -256 | -218 | -142 | -139 | -371 | -325 | -182 | -89 | -83 | -137 | -105 | -200 | -132 | -103 | -100 | -55 | -122 | -63 | 297 | 362 | 95 | 118 | 36 | 9.0 | 701 | 809 | |
| – | – | – | – | – | – | – | – | – | – | – | – | -3.2 | -9.2 | -43.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.2 | 0.0 | – | – | |
| 74.6% | 67.8% | 74.0% | 78.3% | 78.3% | 80.2% | 90.0% | 90.6% | 85.8% | 50.5% | 60.2% | 67.2% | 69.9% | 85.1% | 88.1% | 88.7% | 88.4% | 91.0% | 58.9% | 59.4% | 57.6% | 58.3% | 64.3% | 60.4% | 57.6% | 42.3% | 50.1% | 45.8% | 35.4% | 25.6% | 50.7% | 37.4% | 16.3% | 5.2% | 43.4% | 37.8% | 33.6% | 35.4% | 27.1% | 22.0% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.2 | 7.9 | 0.4 | 0.5 | 0.6 | 0.4 | 1.4 | 1.9 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.14 | -1.04 | -0.80 | -0.61 | -0.46 | -0.47 | -0.53 | -0.62 | -0.57 | -0.31 | 0.10 | 0.46 | 0.70 | 0.55 | 0.09 | -0.24 | -0.82 | -1.00 | -1.06 | -1.21 | -1.35 | -1.75 | -1.04 | -1.46 | -1.66 | -1.46 | -1.39 | -1.69 | -1.91 | -2.76 | -3.82 | -4.34 | -4.91 | -5.12 | -1.07 | -1.07 | -0.01 | 1.44 | -2.11 | -2.23 | |
| 0.00 | 0.06 | 0.18 | 0.30 | 0.42 | 0.41 | 0.26 | 0.16 | 0.17 | 0.49 | 0.97 | 1.38 | 1.74 | 1.68 | 1.37 | 1.21 | 0.86 | 0.78 | 0.86 | 1.03 | 1.32 | 1.38 | 2.44 | 2.36 | 2.30 | 2.62 | 2.52 | 2.39 | 2.24 | 1.69 | 0.29 | 0.16 | 0.22 | 0.21 | 4.23 | 4.29 | 6.11 | 7.75 | 4.37 | 4.67 | |
| 1.34 | 1.37 | 1.26 | 1.20 | 1.09 | 0.95 | 1.36 | 1.17 | 1.00 | 1.80 | 2.05 | 2.29 | 2.52 | 5.15 | 4.86 | 4.84 | 4.49 | 4.42 | 4.29 | 4.20 | 3.91 | 3.56 | 4.19 | 4.29 | 3.77 | 3.56 | 4.13 | 3.41 | 2.53 | 1.49 | 3.92 | 2.66 | 1.52 | 0.42 | 5.08 | 3.76 | 3.43 | 4.04 | 4.31 | 3.25 | |
| -0.96 | -0.59 | -0.57 | -0.47 | -0.43 | -0.69 | -0.61 | -0.62 | -0.51 | 1.40 | 1.32 | 1.53 | 1.66 | -0.35 | -0.45 | -0.87 | -1.04 | -1.19 | 1.59 | 1.61 | 1.41 | 1.18 | -0.69 | -1.13 | -1.79 | -2.23 | -3.27 | -3.20 | -3.07 | -3.74 | -3.81 | -4.28 | -4.95 | -4.58 | 0.07 | -0.13 | 1.16 | 2.29 | -0.36 | -0.52 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.